Measures · D08 in 2016 · Part D · DD3 Member Experience with the Drug Plan
Rating of Drug Plan
Drug PlanMember ExperienceSource: CAHPS
- What it measures
- Percent of the best possible score the plan earned from members who rated the prescription drug plan.
- How it's calculated
- This case-mix adjusted measure is used to assess members' overall view of their prescription drug plan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the mean of the distribution of responses converted to a scale from 0 to 100. The score shown is the percentage of the best possible score each contract earned.
- Data source
- CAHPS CAHPS Survey Questions (question numbers vary depending on survey type): • Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan?
- Measurement period
- 02/15/2015 - 05/31/2015
- Better when
- Higher
- Weight
- 1.5 (Patients’ Experience and Complaints Measure)
- Star assignment
- Relative Distribution and Significance Testing
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- —
- Notes
- CAHPS Survey results were sent to each contract's Medicare Compliance Officer in early August 2015. These reports provide further explanation of the CAHPS scoring methodology and provide detailed information on why a specific rating was assigned.
From the 2016 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA-PD | 84 | 85 | +1 |
| 3★ | MA-PD | 86 | 86 | 0 |
| 4★ | MA-PD | 87 | 87 | 0 |
| 5★ | MA-PD | 89 | 89 | 0 |
| 2★ | PDP | 82 | 82 | 0 |
| 3★ | PDP | 83 | 83 | 0 |
| 4★ | PDP | 86 | 86 | 0 |
| 5★ | PDP | 88 | 88 | 0 |
2016 star distribution
Not rated: Plan too new to be measured (126); Plan too small to be measured (74); Plan not required to report measure (12); Not enough data available (9)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2027 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2026 | MA-PD | < 85 | >= 85 to < 86 | >= 86 to < 88 | >= 88 to < 89 | >= 89 |
| 2026 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2025 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2025 | PDP | < 79 | >= 79 to < 82 | >= 82 to < 85 | >= 85 to < 87 | >= 87 |
| 2024 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 89 | >= 89 |
| 2024 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2023 | MA-PD | < 83 | >= 83 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2023 | PDP | < 79 | >= 79 to < 80 | >= 80 to < 83 | >= 83 to < 87 | >= 87 |
| 2022 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2022 | PDP | < 80 | >= 80 to < 82 | >= 82 to < 84 | >= 84 to < 87 | >= 87 |
| 2021 | MA-PD | < 83 | >= 83 to < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 |
| 2021 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2020 | MA-PD | < 83 | ? 83 to < 84 | ? 84 to < 86 | ? 86 to < 87 | ? 87 |
| 2020 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2019 | MA-PD | < 82 | ? 82 to < 83 | ? 83 to < 85 | ? 85 to < 87 | ? 87 |
| 2019 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 84 | ? 84 to < 86 | ? 86 |
| 2018 | MA-PD | < 81 | ? 81 to < 83 | ? 83 to < 85 | ? 85 to < 86 | ? 86 |
| 2018 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2017 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2017 | PDP | < 79 | ? 79 to < 80 | ? 80 to < 83 | ? 83 to < 86 | ? 86 |
| 2016 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2016 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 82 | ? 82 to < 86 | ? 86 |
| 2015 | MA-PD | < 82% | ? 82% to < 83% | ? 83% to < 84% | ? 84% to < 87% | ? 87% |
| 2015 | PDP | < 80% | ? 80% to < 81% | * | ? 81% to < 86% | ? 86% |
Lowest-scoring contracts, 2016
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H3342 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | — | 75 | 1 | 0 | 9 | 0% |
| S1140 Highmark Blue Cross Blue Shield or Highmark Blue Shield | Highmark Health | 3,185 | 72 | 1 | −3 | 10 | 0% |
| R3332 Florida Blue | Guidewell Mutual Holding Corporation | — | 76 | 1 | 0 | 8 | 0% |
| H3370 EMPIRE HEALTHCHOICE HMO, INC. | Anthem Inc. | — | 76 | 1 | 0 | 8 | 0% |
| H3379 UnitedHealthcare | UnitedHealth Group, Inc. | 102,401 | 77 | 1 | 0 | 7 | 1% |
| H5009 Regence BlueShield | Cambia Health Solutions, Inc. | 10,384 | 77 | 1 | 0 | 7 | 1% |
| H0294 UnitedHealthcare | UnitedHealth Group, Inc. | 71,413 | 77 | 1 | 0 | 7 | 1% |
| H3864 PacificSource Medicare | PacificSource | 52,292 | 78 | 1 | −1 | 6 | 2% |
| R5287 UNITEDHEALTHCARE INSURANCE COMPANY | UnitedHealth Group, Inc. | — | 78 | 1 | 0 | 6 | 2% |
| H8649 Aetna Medicare | CVS Health Corporation | 1,503 | 78 | 1 | −1 | 6 | 2% |
| H1517 ANTHEM INSURANCE COMPANIES, INC. | Anthem Inc. | — | 78 | 1 | −1 | 6 | 2% |
| S7230 MERIDIAN HEALTH PLAN OF MICHIGAN, INC. | Caidan Enterprises, Inc. | — | 77 | 1 | — | 5 | 2% |
| H2836 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 2,426 | 79 | 1 | 0 | 5 | 3% |
| H5826 Community Health Plan of WA Medicare Advantage | Community Health Plan of Washington | 8,875 | 79 | 1 | 0 | 5 | 3% |
| H3327 TOUCHSTONE HEALTH HMO, INC. | Touchstone Health Partnership, Inc | — | 79 | 1 | −1 | 5 | 3% |
| R5342 UnitedHealthcare | UnitedHealth Group, Inc. | 0 | 79 | 1 | −1 | 5 | 3% |
| H8552 Anthem Blue Cross Life and Health Insurance Company | Elevance Health, Inc. | 1,065 | 79 | 1 | 0 | 5 | 3% |
| H3152 Aetna Medicare | CVS Health Corporation | 30,674 | 79 | 1 | −1 | 5 | 3% |
| H5439 Wellcare | Centene Corporation | 19,153 | 79 | 1 | 0 | 5 | 3% |
| H5823 Molina Healthcare of Washington, Inc. | Molina Healthcare, Inc. | 13,098 | 79 | 1 | 0 | 5 | 3% |
| H5422 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 14,085 | 79 | 2 | 0 | 5 | 3% |
| H5414 AETNA HEALTH, INC. (FL) | Aetna Inc. | — | 79 | 1 | −1 | 5 | 3% |
| H3312 Aetna Medicare | CVS Health Corporation | 105,069 | 79 | 1 | −3 | 5 | 3% |
| H3347 Elderplan | Elderplan, Inc. | 27,294 | 79 | 1 | 0 | 5 | 3% |
| H4523 Aetna Medicare | CVS Health Corporation | 39,624 | 79 | 1 | 0 | 5 | 3% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D05 | Rating of Drug Plan | 03/2026 – 06/2026 | 2 | CAHPS |
| 2026 | D05 | Rating of Drug Plan | 03/2025 – 05/2025 | 2 | CAHPS |
| 2025 | D05 | Rating of Drug Plan | 03/2024 – 06/2024 | 4 | CAHPS |
| 2024 | D05 | Rating of Drug Plan | 03/2023 – 06/2023 | 4 | CAHPS |
| 2023 | D05 | Rating of Drug Plan | 03/2022 – 06/2022 | 4 | CAHPS |
| 2022 | D05 | Rating of Drug Plan | 03/2021 – 05/2021 | 2 | CAHPS |
| 2021 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 2 | CAHPS |
| 2020 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 1.5 | CAHPS |
| 2019 | D07 | Rating of Drug Plan | 03/2018 – 06/2018 | 1.5 | CAHPS |
| 2018 | D08 | Rating of Drug Plan | 03/2017 – 06/2017 | 1.5 | CAHPS |
| 2017 | D08 | Rating of Drug Plan | 02/2016 – 08/2016 | 1.5 | CAHPS |
| 2016 | D08 | Rating of Drug Plan | 02/15/2015 - 05/31/2015 | 1.5 | CAHPS |
| 2015 | D06 | Rating of Drug Plan | 02/15/2014 - 05/31/2014 | 1.5 | CAHPS |